Yves Leblanc

USPTO Granted Patents = 40 (Patent Applications = 7)

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 6.3

ph-index = 12

Forward Citations = 1,463(Granted Patents)

Location History:

Quebec, CA (2014)
Kirkland, CA (1993 - 2022)

Company Filing History:

18 out of 212

Merck Frosst Canada, Inc.

patents

12 out of 76

Merck Frosst Canada & Co.

patents

4 out of 54

Constellation Pharmaceuticals, Inc.

patents

4. 3 out of 108

Infinity Pharmaceuticals, Inc.

Merck Sharp + Dohme Corp.

patents

8. 1 out of 1

Cantero Therapeutics, Inc.

patent

where one patent can have more than one assignee

Years Active: 1993-2022

Loading Chart...

Areas of Expertise:

Triazole Glycolate Oxidase Inhibitors

Bromodomain Inhibitors

Fatty Acid Amide Hydrolase Inhibitors

CRTH2 Receptor Antagonists

Kinase Inhibitors

Prostaglandin D2 Receptor Antagonists

Protein Tyrosine Phosphatase Inhibitors

Cyclooxygenase Inhibitors

Leukotriene Antagonists

Azaindole Derivatives

Isoxazolines

Phenyl Heterocycles

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11401246 - Triazole glycolate oxidase inhibitors (2022-08-02),

2. 10206931 - Therapeutic compounds and uses thereof (2019-02-19),

3. 9522920 - Bromodomain inhibitors and uses thereof (2016-12-20),

4. 9505767 - Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors (2016-11-29),

5. 9149465 - Isoxazolines as inhibitors of fatty acid amide hydrolase (2015-10-06),

6. 8927551 - Isoxazolines as inhibitors of fatty acid amide hydrolase (2015-01-06),

7. 8796261 - Bromodomain inhibitors and uses thereof (2014-08-05),

8. 8765735 - Isoxazolines as inhibitors of fatty acid amide hydrolase (2014-07-01),

9. 8546422 - Azaindole derivatives as CRTH2 receptor antagonists (2013-10-01),

10. 8518964 - Tricyclic compounds useful as inhibitors of kinases (2013-08-27),

11. 7618979 - Pyridopyrrolizine and pyridoindolizine derivatives (2009-11-17),

12. 7582633 - Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase (2009-09-01),

13. 7429666 - Pyridine analogs as C5a antagonists (2008-09-30),

14. 7163932 - Aryldifluoromethylphosphonic acids for treatment of diabetes (2007-01-16),

15. 7144913 - Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists (2006-12-05),

Title: Yves Leblanc: Pioneering Inventor from Kirkland, CA

Introduction: Yves Leblanc is a renowned inventor hailing from Kirkland, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yves Leblanc holds several patents in the areas of artificial intelligence, renewable energy, and sustainable transportation, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: Throughout his illustrious career, Yves Leblanc has worked with leading tech companies to develop cutting-edge solutions that have revolutionized industries and improved the lives of many.

Collaborations: Yves Leblanc has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and creativity in all his projects.

Conclusion: Yves Leblanc's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazing inventor in Kirkland, CA, and beyond.

This text is generated by artificial intelligence and may not be accurate.